BA

The Boeing Company

57
Fundamentals73/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential20/ 100

BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

KEX

Kirby Corporation

73
Fundamentals70/ 100
Valuation69/ 100
Upside potential74/ 100
Risk potential14/ 100

KEX has the edge over BA overall, supported by stronger valuation and stronger modeled upside.

BA Fundamentals

MetricStatus
Stable
Healthy
Stable
Under pressure

BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.

KEX Fundamentals

MetricStatus
Healthy
Healthy
Healthy
Healthy

KEX's revenue, profitability, cash flow and balance sheet are all currently healthy.

BA PE Valuation

CHEAPFAIREXPENSIVE25x51x76x102x
CHEAPFAIREXPENSIVE25x51x76x102x
LevelPEPriceVs current
Current18x$172—
Cheap51x$496+189%
Fair82x$790+360%
Expensive91x$876+411%

Historical ranges are pointers, not guarantees.

BA has the edge over KEX in the historical PE scenario, which offers more potential upside but is not a forecast.

KEX PE Valuation

CHEAPFAIREXPENSIVE16x32x48x64x
CHEAPFAIREXPENSIVE16x32x48x64x
LevelPEPriceVs current
Forward15x$129—
Current19x$129—
Cheap20x$142+11%
Fair24x$168+30%
Expensive41x$286+122%

Historical ranges are pointers, not guarantees.

KEX's PE is in its cheap range at 19x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.

BA Forward outlook

MetricOutlook
--
Returning to profit
Growth
Improving
Limited
Low

Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.

KEX Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Improving
Limited
High

Analysts expect earnings and revenue growth for KEX, with profitability improving.

BA Risk to reward

ScenarioChangePrice
Upside+26%$216.09
Downside-20%$137.47

Calculated from the latest close: $171.55 on Nov 12.

BA trails KEX on modeled risk to reward, with less potential upside and more potential downside.

KEX Risk to reward

ScenarioChangePrice
Upside+38%$177.52
Downside-14%$111.00

Calculated from the latest close: $128.51 on Nov 12.

KEX has a better modeled risk to reward balance than BA, with more potential upside and less potential downside.

BA Earnings Per Share

Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
QuarterTTM EPSYoY
Q3 2026$9.66+$23.38
Q2 2026$2.78+$19.33
Q1 2026$2.53+$20.49
Q4 2025$2.48+$20.84
Q3 2025-$13.72-$0.83
Q2 2025-$16.55-$10.93
Q1 2025-$17.96-$14.42
Q4 2024-$18.36-$14.69

BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.

KEX Earnings Per Share

Q4 2023: $3.72Q1 2024: $4.23Q2 2024: $4.71Q3 2024: $5.21Q4 2024: $4.91Q1 2025: $5.05Q2 2025: $5.29Q3 2025: $5.39Q4 2025: $6.33Q1 2026: $6.50Q2 2026: $6.50Q3 2026: $6.94Forward: $8.31
Q4 2023: $3.72Q1 2024: $4.23Q2 2024: $4.71Q3 2024: $5.21Q4 2024: $4.91Q1 2025: $5.05Q2 2025: $5.29Q3 2025: $5.39Q4 2025: $6.33Q1 2026: $6.50Q2 2026: $6.50Q3 2026: $6.94Forward: $8.31
QuarterTTM EPSYoY
Forward$8.31+20%
Q3 2026$6.94+29%
Q2 2026$6.50+23%
Q1 2026$6.50+29%
Q4 2025$6.33+29%
Q3 2025$5.39+3.5%
Q2 2025$5.29+12%
Q1 2025$5.05+19%
Q4 2024$4.91+32%

KEX has the edge over BA on earnings, with more consistent year-over-year improvement.

BA Quarterly Revenue

Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
QuarterRevenueYoY
Q3 2026$24.2B+3.9%
Q2 2026$24.6B+8%
Q1 2026$22.2B+14%
Q4 2025$23.9B+57%
Q3 2025$23.3B+30%
Q2 2025$22.7B+35%
Q1 2025$19.5B+18%
Q4 2024$15.2B-31%

BA has the edge over KEX on sales, with stronger typical year-over-year growth.

KEX Quarterly Revenue

Q4 2023: $799MQ1 2024: $808MQ2 2024: $824MQ3 2024: $831MQ4 2024: $802MQ1 2025: $786MQ2 2025: $855MQ3 2025: $871MQ4 2025: $852MQ1 2026: $844MQ2 2026: $922MQ3 2026: $977M
Q4 2023: $799MQ1 2024: $808MQ2 2024: $824MQ3 2024: $831MQ4 2024: $802MQ1 2025: $786MQ2 2025: $855MQ3 2025: $871MQ4 2025: $852MQ1 2026: $844MQ2 2026: $922MQ3 2026: $977M
QuarterRevenueYoY
Q3 2026$977.2M+12%
Q2 2026$922.4M+7.8%
Q1 2026$844.1M+7.4%
Q4 2025$851.8M+6.2%
Q3 2025$871.2M+4.8%
Q2 2025$855.5M+3.8%
Q1 2025$785.7M-2.8%
Q4 2024$802.3M+0.4%

KEX's revenue has grown year over year for six quarters in a row: $977M last quarter, up 12% from the same quarter a year ago.

BA Free Cash Flow

Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
QuarterFree cash flowYoY
Q3 2026$464M+95%
Q2 2026$631M+$831M
Q1 2026-$1.5B+$836M
Q4 2025$375M+$4.5B
Q3 2025$238M+$2.2B
Q2 2025-$200M+$4.1B
Q1 2025-$2.3B+$1.6B
Q4 2024-$4.1B-239%

BA has the edge over KEX on cash flow, with more consistent year-over-year improvement.

KEX Free Cash Flow

Q4 2023: $89MQ1 2024: $42MQ2 2024: $91MQ3 2024: $130MQ4 2024: $151MQ1 2025: −$42MQ2 2025: $22MQ3 2025: $160MQ4 2025: $265MQ1 2026: $49MQ2 2026: $758,000Q3 2026: $74M
Q4 2023: $89MQ1 2024: $42MQ2 2024: $91MQ3 2024: $130MQ4 2024: $151MQ1 2025: −$42MQ2 2025: $22MQ3 2025: $160MQ4 2025: $265MQ1 2026: $49MQ2 2026: $758,000Q3 2026: $74M
QuarterFree cash flowYoY
Q3 2026$73.9M-54%
Q2 2026$758K-97%
Q1 2026$49.4M+$91.5M
Q4 2025$265.2M+76%
Q3 2025$160.3M+23%
Q2 2025$22.4M-75%
Q1 2025-$42.1M-200%
Q4 2024$150.7M+69%

KEX generated $389M in free cash flow over the past year, up 34% from the year before.

BA Total Shares

Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
PeriodChange %Net change
Quarterly+0.3%+2.1M shares
1 year+4.3%+32.8M shares
3 years+31%+186M shares
5 years+35%+204M shares
Available history+40%+227M shares

BA has 793M diluted shares, up 4.3% from a year ago.

KEX Total Shares

Q4 2023: 60MQ1 2024: 59MQ2 2024: 59MQ3 2024: 58MQ4 2024: 58MQ1 2025: 57MQ2 2025: 56MQ3 2025: 56MQ4 2025: 56MQ1 2026: 54MQ2 2026: 54MQ3 2026: 53M
Q4 2023: 60MQ1 2024: 59MQ2 2024: 59MQ3 2024: 58MQ4 2024: 58MQ1 2025: 57MQ2 2025: 56MQ3 2025: 56MQ4 2025: 56MQ1 2026: 54MQ2 2026: 54MQ3 2026: 53M
PeriodChange %Net change
Quarterly-1.3%-677K shares
1 year-5.3%-3M shares
3 years-11%-6.7M shares
5 years-11%-6.9M shares

KEX has the edge over BA on shareholder dilution, with a more favorable share count trend.

BA Net Leverage

Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
QuarterNet LeverageStatus
Q3 20263.0xElevated
Q2 20265.7xHigh
Q1 20266.0xHigh
Q4 20256.9xHigh
Q2 2024361.8xHigh
Q1 202436.1xHigh
Q4 202336.4xHigh
Q3 202396.1xHigh

BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.

KEX Net Leverage

Q4 2023: 1.8xQ1 2024: 1.7xQ2 2024: 1.6xQ3 2024: 1.3xQ4 2024: 1.2xQ1 2025: 1.6xQ2 2025: 1.6xQ3 2025: 1.5xQ4 2025: 1.1xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.3x
Q4 2023: 1.8xQ1 2024: 1.7xQ2 2024: 1.6xQ3 2024: 1.3xQ4 2024: 1.2xQ1 2025: 1.6xQ2 2025: 1.6xQ3 2025: 1.5xQ4 2025: 1.1xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.3x
QuarterNet LeverageStatus
Q3 20261.3xHealthy
Q2 20261.3xHealthy
Q1 20261.2xHealthy
Q4 20251.1xHealthy
Q3 20251.5xHealthy
Q2 20251.6xHealthy
Q1 20251.6xHealthy
Q4 20241.2xHealthy

KEX has the edge over BA on leverage, with a lower net debt burden relative to earnings.

BA Weekly Momentum

MetricValueStatus
RSI31.1Neutral
Stochastic9.6Oversold

BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).

KEX Weekly Momentum

MetricValueStatus
RSI45.9Neutral
Stochastic40.6Neutral

KEX's weekly RSI is 46 (neutral) and its Stochastic is 41 (neutral).

BA PE vs Industrials Sector

MetricBASector medianRelative
PE18x24x26% below
PE %05858 pts below

BA has the edge over KEX on valuation relative to its sector.

KEX PE vs Industrials Sector

MetricKEXSector medianRelative
PE19x24x23% below
PE %65852 pts below

KEX is trading at 19x earnings, a 23% discount to the Industrials sector's median of 24x.

BA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$184.67.1% below
20 week MA$203.816% below
50 week MA$215.520% below
100 week MA$205.917% below
200 week MA$200.614% below

BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.

KEX Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$133.33.6% below
20 week MA$136.65.9% below
50 week MA$133.23.5% below
100 week MA$117.79.1% above
200 week MA$105.222% above

KEX has the edge over BA on trend strength, trading above more of its moving averages.

BA Yearly ROI

YearStart priceEnd priceROI
2020$330.1$217.2-34%
2021$217.2$204.2-6%
2022$204.2$189.1-7.4%
2023$189.1$260.7+38%
2024$260.7$180.7-31%
2025$180.7$216.4+20%
2026 YTD$216.4$171.6-21%

BA has finished lower in four of the last six years. It's down 21% so far in 2026.

KEX Yearly ROI

YearStart priceEnd priceROI
2020$88.5$51.4-42%
2021$51.4$59.7+16%
2022$59.7$64.4+7.9%
2023$64.4$78.5+22%
2024$78.5$106.0+35%
2025$106.0$110.9+4.6%
2026 YTD$110.9$128.5+16%

KEX has the edge over BA on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key